Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In short12-week pill that cures hepatitis C.Backbone drug for HIV treatment, PrEP and hepatitis B.
Body systemAntiviralsAntivirals
Drug classHepatitis C direct-acting antiviralsNucleos(t)ide reverse transcriptase inhibitors
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesChronic hepatitis C (all genotypes)HIV treatment, HIV pre-exposure prophylaxis (PrEP, with emtricitabine), Chronic hepatitis B
How it worksBlocks two proteins the hepatitis C virus needs to copy itself.A fake DNA building block that stops HIV and hepatitis B copying themselves.
Starts working——
Half-lifeAbout 15 hours (velpatasvir)About 17 hours in plasma
Typical adult doseOne tablet (400/100 mg) once a day for 12 weeks.300 mg (245 mg tenofovir disoproxil) once a day.
FormsTabletTablet, Combination tablets
Common side effectsHeadache, Tiredness, NauseaNausea, Diarrhoea, Headache, Dizziness
Serious side effectsSevere slow heart rate with amiodarone, Hepatitis B reactivationKidney damage, Bone thinning, Hepatitis B flare if stopped suddenly
Don't take if——
Alcohol——
PregnancyUse with cautionNot routinely used in pregnancy yet; data emerging.Generally considered safeWidely used in pregnancy for HIV and hepatitis B.
Breastfeeding——
In use since20162001
Brand namesUnited States: EpclusaUnited Kingdom: EpclusaIndia: Velpanat, Myhep AllUnited States: Viread, Truvada (with emtricitabine)United Kingdom: Viread, TruvadaIndia: Tenvir
Legal status——
ATC codeJ05AP55J05AF07

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker